US 7947698
Compositions and methods for inhibition of the JAK pathway
granted A61PA61P37/00A61P37/06
Quick answer
US patent 7947698 (Compositions and methods for inhibition of the JAK pathway) held by Rigel Pharmaceuticals, Inc. expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 54
- CPC classes
- A61P, A61P37/00, A61P37/06